Real-World Evidence Sought In Sanofi Pasteur Observational Flu Vaccine Trial

 
• By Sten Stovall

Vaccine maker Sanofi Pasteur and managed care group Kaiser Permanente have joined forces in an observational trial using electronic medical records from 1.6 million people to highlight the benefits of integrated big data.

ERM
Pharma Wants More Regulatory Acceptance Of Electronic Observational Studies • Source: Shutterstock

More from Clinical Trials

More from R&D